These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3837002)

  • 1. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction.
    Jaffe AS; Eisenberg PR; Wilner GD
    Prog Hematol; 1987; 15():71-89. PubMed ID: 3332392
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
    Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 6. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of plasma D-dimer contents in patients with coronary heart disease].
    Huang C; Xu M; Zhao Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):551-2. PubMed ID: 10073007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
    Ikonnikova EI; Katkova NB; Filippova SB
    Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin generation and digestion in patients with angina pectoris.
    Prisco D; Paniccia R; Francalanci I; Bandinelli B; Filippini M; Bacci F; Rostagno C; Abbate R; Gensini GF
    Int J Clin Lab Res; 1995; 25(4):222-5. PubMed ID: 8788552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma fibrinolytic activity following oral anabolic steroid therapy.
    Walker ID; Davidson JF; Young P; Conkie JA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):236-45. PubMed ID: 1103357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of fibrinolytic enzymes by macrophages in response to soluble fibrin.
    Sherman LA; Lee JL; Stewart CC
    J Reticuloendothel Soc; 1981 Nov; 30(5):317-29. PubMed ID: 7198690
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
    Braun P; Meskó E; Gedeon A
    Z Gesamte Inn Med; 1976 Sep; 31(18):758-9. PubMed ID: 1007337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypofibrinolysis and thrombophilia].
    Cepelák V; Dvorák J; Cepeláková H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased myocardial fibrinolytic activity following temporary ischaemia and reperfusion.
    Cherry GW; Opie LH
    Thromb Diath Haemorrh; 1975 Sep; 34(1):210-5. PubMed ID: 810911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.